The dividend is small and routine; the more significant event is the pending Merck KGaA acquisition, which conditions the dividend payment. Monitor for shareholder vote and regulatory approvals on the acquisition.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $72.73entry
- T+1 · 12d ago −0.10%α +4.31% · $72.66
- T+5 · 6d ago +0.10%α +1.01% · $72.80
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bio-Techne filed an 8-K announcing a quarterly cash dividend of $0.08 per share for the quarter ended September 30, 2026, payable on November 23, 2026 to holders of record on November 13, 2026. The dividend is contingent on the pending acquisition by Merck KGaA not closing on or before the record date. This is a routine capital allocation event with no material financial impact.
Key Facts
- Quarterly dividend of $0.08 per share declared for the quarter ended September 30, 2026
- Payable November 23, 2026 to shareholders of record on November 13, 2026
- Dividend is contingent on the pending Merck KGaA acquisition not closing on or before November 13, 2026
- Future dividends to be considered quarterly by the Board
- Company generated over $1.2 billion in net sales in fiscal 2026
Financial Impact
Quarterly dividend of $0.08 per share; total payout not specified but represents a routine capital return
Risk Factors
- Dividend may be cancelled if the Merck KGaA acquisition closes before the record date
- No material financial risk from this filing alone
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-122283 |
| Document: tech-ex99d1.htm | 0001104659-26-122283 |
| Document: 0001104659-26-122283-index-headers.html | 0001104659-26-122283 |
| Document: 0001104659-26-122283-index.html | 0001104659-26-122283 |
| Document: 0001104659-26-122283.txt | 0001104659-26-122283 |
Track record
12 reports on TECH
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +2.07% at T+60 after the Jun 25, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago 10-Q/A Neutral 1/10 Entry $72.80 Now $72.80 +0.00% settles Dec 14
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $72.66 Now $72.80 +0.19% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Viewing Entry $72.73 Now $72.80 +0.10% settles Dec 3
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $72.73 Now $72.80 +0.10% settles Dec 3
- Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $72.71 Now $72.80 −0.12% settles Nov 27
- Oct 28, 202619d ago 10-K/A Neutral 3/10 Entry $72.71 Now $72.80 +0.12% settles Nov 27
- Sep 23, 20267w ago 8-K Bullish 6/10 Entry $72.57 to $72.62 Now $72.80 +0.32% ▲ +0.07% +0.49% vs SPY
- Sep 23, 20267w ago Press Release Bullish 6/10 Entry $72.52 to $72.64 Now $72.80 +0.39% ▲ +0.17% −0.52% vs SPY
- Aug 12, 202613w ago 8-K Bullish 7/10 No price data
- Aug 12, 202613w ago Press Release Neutral 4/10 Entry $72.23 to $72.08 Now $72.80 +0.79% ▼ −0.21% +1.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers